Skip to content
Preprint · OA via OpenAlex

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

Daniel Francis Martin, Maureen G. Maguire, Stuart L. Fine, Gui‐Shuang Ying, Glenn J. Jaffe, Juan E. Grunwald, Cynthia Ann Toth, Maryann Redford, Frederick L. Ferris

Ophthalmology · 2012 · ▲ 1,713 citations

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.ophtha.2012.03.053
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Martin, D.F., Maguire, M.G., Fine, S.L., Ying, G., Jaffe, G.J., Grunwald, J.E., Toth, C.A., Redford, M., &amp; Ferris, F.L. (2012). Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration. <em>Ophthalmology</em>. https://doi.org/10.1016/j.ophtha.2012.03.053
Vancouver
Martin DF, Maguire MG, Fine SL, Ying G, Jaffe GJ, Grunwald JE, et al. Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration. Ophthalmology. 2012. doi:10.1016/j.ophtha.2012.03.053.
BibTeX
@unpublished{daniel2012Ranibi, title = {Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration}, author = {Daniel Francis Martin and Maureen G. Maguire and Stuart L. Fine and Gui‐Shuang Ying and Glenn J. Jaffe and Juan E. Grunwald and Cynthia Ann Toth and Maryann Redford and Frederick L. Ferris}, journal = {Ophthalmology}, year = {2012}, doi = {10.1016/j.ophtha.2012.03.053}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings